<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><description>医药行业一致性评价工作在如火如荼的进行中，作为行业的一份子，愿本愚公之念，出蝼蚁 之力，献寸光之策。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 07 May 2021 23:24:50 +0800</pubDate><image><url>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</url><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>畅销降糖药Top 10排行，GLP-1、DPP-4潜力突显！</title><link>https://mp.weixin.qq.com/s/r627HeQ8odJVsN_X_jp8VQ</link><description></description><content:encoded><![CDATA[畅销降糖药Top 10排行，GLP-1、DPP-4潜力突显！]]></content:encoded><pubDate>Fri, 07 May 2021 21:36:47 +0800</pubDate></item><item><title>国采品种：药价大调整，涉及500多个品规...</title><link>https://mp.weixin.qq.com/s/rcmekpXUtf0pk1ovvdR7DA</link><description></description><content:encoded><![CDATA[国采品种：药价大调整，涉及500多个品规...]]></content:encoded><pubDate>Fri, 07 May 2021 21:36:47 +0800</pubDate></item><item><title>59品规联动降价，最高降幅75.66%！</title><link>https://mp.weixin.qq.com/s/PJ95Q7OYHOx7oFNrXwcVOg</link><description></description><content:encoded><![CDATA[59品规联动降价，最高降幅75.66%！]]></content:encoded><pubDate>Fri, 07 May 2021 21:36:47 +0800</pubDate></item><item><title>【Q&amp;A】CDE解答化学仿制药 - 共性问题</title><link>https://mp.weixin.qq.com/s/7GAe62a1qwcPse3J_s4HGg</link><description></description><content:encoded><![CDATA[【Q&A】CDE解答化学仿制药 - 共性问题]]></content:encoded><pubDate>Fri, 07 May 2021 21:36:47 +0800</pubDate></item><item><title>一致性评价榜单出炉，齐鲁、科伦、人福、石药势均力敌！</title><link>https://mp.weixin.qq.com/s/BMpz1Mx0gmnFu3DhBYPiVg</link><description></description><content:encoded><![CDATA[一致性评价榜单出炉，齐鲁、科伦、人福、石药势均力敌！]]></content:encoded><pubDate>Thu, 06 May 2021 21:37:33 +0800</pubDate></item><item><title>二甲双胍，屡现新奇！</title><link>https://mp.weixin.qq.com/s/RZSMSEY6cfDRHssnv3tZ4Q</link><description></description><content:encoded><![CDATA[二甲双胍，屡现新奇！]]></content:encoded><pubDate>Thu, 06 May 2021 21:37:33 +0800</pubDate></item><item><title>福建丨229品规大集采，明天报价，后天开标！</title><link>https://mp.weixin.qq.com/s/WmlzzqTdrVp48wt_SeygSQ</link><description></description><content:encoded><![CDATA[福建丨229品规大集采，明天报价，后天开标！]]></content:encoded><pubDate>Thu, 06 May 2021 21:37:33 +0800</pubDate></item><item><title>【关注】MAH变更最新要求</title><link>https://mp.weixin.qq.com/s/EyOdwX6KOA5PrT4vwGKNKg</link><description></description><content:encoded><![CDATA[【关注】MAH变更最新要求]]></content:encoded><pubDate>Thu, 06 May 2021 21:37:33 +0800</pubDate></item><item><title>Me too 药物：别过来，这边有点挤！</title><link>https://mp.weixin.qq.com/s/qOz2kryOY-H2gDqBjqmjHw</link><description></description><content:encoded><![CDATA[Me too 药物：别过来，这边有点挤！]]></content:encoded><pubDate>Wed, 05 May 2021 14:34:57 +0800</pubDate></item><item><title>700亿多肽药物市场，欧洲原料药企倾巢而来！</title><link>https://mp.weixin.qq.com/s/_ONST0b37WyadopUIMhOhA</link><description></description><content:encoded><![CDATA[700亿多肽药物市场，欧洲原料药企倾巢而来！]]></content:encoded><pubDate>Mon, 03 May 2021 21:35:38 +0800</pubDate></item><item><title>去氨加压素，一个似乎被市场忽略的品种</title><link>https://mp.weixin.qq.com/s/bj4nU_L7dUPxDEr1iYEE4Q</link><description></description><content:encoded><![CDATA[去氨加压素，一个似乎被市场忽略的品种]]></content:encoded><pubDate>Mon, 03 May 2021 21:35:38 +0800</pubDate></item><item><title>奥曲肽和天然生长抑素，近20亿元市场</title><link>https://mp.weixin.qq.com/s/LhR_U5OTZE8aVKZ080v9-Q</link><description></description><content:encoded><![CDATA[奥曲肽和天然生长抑素，近20亿元市场]]></content:encoded><pubDate>Mon, 03 May 2021 21:35:38 +0800</pubDate></item><item><title>阿托西班，增长的市场是否已满？</title><link>https://mp.weixin.qq.com/s/CKaa5lwRCrTHTl63dwQJ-A</link><description></description><content:encoded><![CDATA[阿托西班，增长的市场是否已满？]]></content:encoded><pubDate>Mon, 03 May 2021 21:35:38 +0800</pubDate></item><item><title>曲普瑞林，潜在“金矿”，原研同款原料药</title><link>https://mp.weixin.qq.com/s/CWqTRUzOhEA_ps4JlznPCw</link><description></description><content:encoded><![CDATA[曲普瑞林，潜在“金矿”，原研同款原料药]]></content:encoded><pubDate>Mon, 03 May 2021 21:35:38 +0800</pubDate></item><item><title>艾塞那肽，拥挤的降糖市场，GLP-1以多种剂型切入</title><link>https://mp.weixin.qq.com/s/QJfE14zVyXXnkJAZBCcB9A</link><description></description><content:encoded><![CDATA[艾塞那肽，拥挤的降糖市场，GLP-1以多种剂型切入]]></content:encoded><pubDate>Mon, 03 May 2021 21:35:38 +0800</pubDate></item><item><title>利拉鲁肽，超200亿的国际市场</title><link>https://mp.weixin.qq.com/s/VlMkPkjYffEG8vacweukdA</link><description></description><content:encoded><![CDATA[利拉鲁肽，超200亿的国际市场]]></content:encoded><pubDate>Mon, 03 May 2021 21:35:38 +0800</pubDate></item><item><title>轰轰烈烈的一致性评价和集采，点燃了参比制剂和原料药！</title><link>https://mp.weixin.qq.com/s/TI173qWILBcgMXkaQZU3bg</link><description></description><content:encoded><![CDATA[轰轰烈烈的一致性评价和集采，点燃了参比制剂和原料药！]]></content:encoded><pubDate>Sun, 02 May 2021 21:59:28 +0800</pubDate></item><item><title>过评“大爆发”，50品规齐迎喜讯，注射剂占比过半…</title><link>https://mp.weixin.qq.com/s/h_rP2XXC2E6DAnxoKO46hA</link><description></description><content:encoded><![CDATA[过评“大爆发”，50品规齐迎喜讯，注射剂占比过半…]]></content:encoded><pubDate>Fri, 30 Apr 2021 21:44:02 +0800</pubDate></item><item><title>多个省际联盟集采，最终实施方案来了！</title><link>https://mp.weixin.qq.com/s/xr6yE_sCcLJZ42HegwFg3g</link><description></description><content:encoded><![CDATA[多个省际联盟集采，最终实施方案来了！]]></content:encoded><pubDate>Fri, 30 Apr 2021 21:44:02 +0800</pubDate></item><item><title>19个国谈药被医保局点名了！</title><link>https://mp.weixin.qq.com/s/wO9VH6fvIGo1sY2c8lFiZA</link><description></description><content:encoded><![CDATA[19个国谈药被医保局点名了！]]></content:encoded><pubDate>Fri, 30 Apr 2021 21:44:02 +0800</pubDate></item></channel></rss>